Cyclerion Therapeutics, Inc. — Form D

Cyclerion Therapeutics, Inc. of Cambridge, MA, a company, filed a Form D exempt-offering notice with the SEC on 2023-05-25. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (44)

Showing 25 of 44 people.

NameRoleLocation
Errol M De SouzaDirectorCambridge, MA
Peter M HechtDirectorCambridge, MA
Steven M HymanDirectorCambridge, MA
Ole M IsacsonDirectorCambridge, MA
Terrance M McGuireDirectorCambridge, MA
Cheryl M GaultExecutive OfficerCambridge, MA
Anjeza M GjinoExecutive OfficerCambridge, MA
Peter M HechtExecutive OfficerCambridge, MA
Amy SchulmanRelated PersonCambridge, MA
Michael MendelsohnRelated PersonCambridge, MA
Stephanie LovellRelated PersonCambridge, MA
Terrance G McGuireDirectorBoston, MA
MARK G CURRIEExecutive OfficerCAMBRIDGE, MA
Terrance McGuireRelated PersonCambridge, MA
Amy E SchulmanDirectorNew York, NY
Stephanie M LovellDirectorCambridge, MA
Kevin M ChurchwellDirectorCambridge, MA
George M ConradesDirectorCambridge, MA
Michael M MendelsohnDirectorCambridge, MA
Marsha M FanucciDirectorCambridge, MA
Andreas M BuschExecutive OfficerCambridge, MA
Kevin E ChurchwellDirectorCambridge, MA
Terrance E McGuireDirectorCambridge, MA
Marsha E FanucciDirectorCambridge, MA
Ole E IsacsonDirectorCambridge, MA

Other filings by this issuer (3)

FiledFormOfferingSold
2021-06-17D$18.0M$18.0M
2020-08-11D$24.3M$24.3M
2019-04-17D$175.0M$175.0M

More